Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-12-15 5:00 pm Sale | 13D | Ventyx Biosciences Inc. VTYX | venBio Global Strategic Fund III L.P. | 3,470,496 6.1% | -1,541,040 (-30.75%) | View |
| 2022-11-09 5:04 pm Sale | 13D | Ventyx Biosciences Inc. VTYX | Third Point LLC | 2,252,432 4% | -2,060,402 (-47.77%) | View |
| 2022-09-20 9:25 pm Unchanged | 13D | Ventyx Biosciences Inc. VTYX | NSV Investments I L.P. | 16,892,528 30% | 0 (Unchanged) | View |
| 2022-09-14 5:01 pm Unchanged | 13D | Ventyx Biosciences Inc. VTYX | venBio Global Strategic Fund III L.P. | 5,011,536 9.95% | 0 (Unchanged) | View |
| 2022-02-14 06:26 am Purchase | 13G | Ventyx Biosciences Inc. VTYX | CITADEL ADVISORS LLC | 3,891,073 7.7% | 455,133 (+13.25%) | View |
| 2021-11-04 5:11 pm Purchase | 13D | Ventyx Biosciences Inc. VTYX | Third Point LLC | 4,312,834 8.57% | 4,312,834 (New Position) | View |
| 2021-11-04 4:21 pm Purchase | 13G | Ventyx Biosciences Inc. VTYX | CITADEL ADVISORS LLC | 3,435,940 6.8% | 3,435,940 (New Position) | View |
| 2021-11-04 4:15 pm Purchase | 13D | Ventyx Biosciences Inc. VTYX | venBio Global Strategic Fund III L.P. | 5,011,536 9.95% | 5,011,536 (New Position) | View |
| 2021-10-29 4:50 pm Purchase | 13D | Ventyx Biosciences Inc. VTYX | NSV Investments I L.P. | 16,892,528 33.6% | 16,892,528 (New Position) | View |